Sun Pharmaceutical (India) Today
| SUNPHARMA | 1,795 15.30 0.86% |
Performance0 of 100
| Odds Of DistressLess than 1
|
Sun Pharmaceutical is selling at 1795.30 as of the 25th of November 2024; that is 0.86 percent increase since the beginning of the trading day. The stock's lowest day price was 1768.05. Sun Pharmaceutical has a very small chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Sun Pharmaceutical Industries are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 26th of October 2024 and ending today, the 25th of November 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | Category Healthcare | Classification Health Care |
Sun Pharmaceutical is entity of India. It is traded as Stock on NSE exchange. The company has 2.4 B outstanding shares. More on Sun Pharmaceutical Industries
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Sun Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Sun Pharmaceutical's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Sun Pharmaceutical or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary, Sun Pharmaceutical's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Sun Pharmaceutical's managers, analysts, and investors.
Environment Score | Governance Score | Social Score |
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Pharmaceuticals, Drug Manufacturers-Specialty & Generic, Healthcare (View all Sectors) | ||||
| Excise Tax Activities | Animal TestingCatholic | ||||
Sun Pharmaceutical's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Sun Pharmaceutical's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsSun Pharmaceutical can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Sun Pharmaceutical's financial leverage. It provides some insight into what part of Sun Pharmaceutical's total assets is financed by creditors.
| |||||
Sun Pharmaceutical Industries (SUNPHARMA) is traded on National Stock Exchange of India in India and employs 43,000 people. Sun Pharmaceutical is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Mega-Cap' category with a current market capitalization of 4.31 T. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Sun Pharmaceutical's market, we take the total number of its shares issued and multiply it by Sun Pharmaceutical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Sun Pharmaceutical operates under Pharmaceuticals sector and is part of Health Care industry. The entity has 2.4 B outstanding shares.
Sun Pharmaceutical Industries has accumulated about 13.87 B in cash with 121.35 B of positive cash flow from operations.
Check Sun Pharmaceutical Probability Of Bankruptcy
Ownership AllocationSun Pharmaceutical shows a total of 2.4 Billion outstanding shares. Sun Pharmaceutical maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Sun Ownership Details
Sun Pharmaceutical Risk Profiles
Although Sun Pharmaceutical's alpha and beta are two of the key measurements used to evaluate Sun Pharmaceutical's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 0.8273 | |||
| Semi Deviation | 1.04 | |||
| Standard Deviation | 1.07 | |||
| Variance | 1.14 |
Sun Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Sun Pharmaceutical without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Stocks Directory Now
Stocks DirectoryFind actively traded stocks across global markets |
| All Next | Launch Module |
Sun Pharmaceutical Corporate Management
Elected by the shareholders, the Sun Pharmaceutical's board of directors comprises two types of representatives: Sun Pharmaceutical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Sun. The board's role is to monitor Sun Pharmaceutical's management team and ensure that shareholders' interests are well served. Sun Pharmaceutical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Sun Pharmaceutical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Dheeraj BE | EVP Officer | Profile | |
| Abhishek Sharma | Head VP | Profile | |
| Abhay Gandhi | Chief Business | Profile | |
| Kirti Ganorkar | Chief Business | Profile | |
| Sailesh Desai | Whole Director | Profile | |
| Sapna Purohit | VP HR | Profile | |
| Dilip Shanghvi | MD Director | Profile |
Additional Tools for Sun Stock Analysis
When running Sun Pharmaceutical's price analysis, check to measure Sun Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sun Pharmaceutical is operating at the current time. Most of Sun Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Sun Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sun Pharmaceutical's price. Additionally, you may evaluate how the addition of Sun Pharmaceutical to your portfolios can decrease your overall portfolio volatility.